Wolchko J Scott's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Jan 24, 2022
- Accession no.
- 0001209191-22-004606
- Filed
- Jan 24, 2022
- Trade date
- Jan 20-21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.59M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000899243-22-004871 (Feb 4, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wolchko J ScottCIK 0001586893 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $2.73 | +$81,900 | 461,546 | Direct | |
| Jan 20, 2022 | Common Stock | SSaleDisposed | −30,000 | $40.21 | −$1,206,300 | 431,546 | Direct | |
| Jan 21, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $2.70 | +$27,000 | 441,546 | Direct | |
| Jan 21, 2022 | Common Stock | SSaleDisposed | −10,000 | $38.02 | −$380,200 | 431,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $2.73 | −$81,900 | 20,000 | Direct | |
| Jan 21, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $2.70 | −$27,000 | 89,446 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.